1.In vitro generation and function analysis of CD4~+CD25~+ regulatory T cell from the healthy volunteers
Zhenpeng DAI ; Jincun ZHAO ; Yan ZHANG ; Al ET
Chinese Journal of Immunology 1985;0(01):-
Objective:To establish and characterize human CD4 +CD25 + T cell lines Methods:CD4 +CD25 + T cells were isolated from healthy volunteers and expanded in vitro Their suppressive effect on the proliferation of CD4 + T cells was analyzed in proliferation assays Phenotype of the T cell lines was determined by FACS Results:Long term cultured CD4 +CD25 +T cells were hyporesponsive to stimulation via their T cell receptor In co culture experiments CD4 +CD25 + T cells could suppress the activation and proliferation of CD4 + T cells, and the suppression was abrogated when exogenous IL 2 was provided In vitro expanded human CD4 +CD25 + T cells remained positive for CD25 and CTLA 4 expression Conclusion:CD4 +CD25 + T cells can be established as long term cultured T cell lines while still maintaining their suppressive function and distinctive phenotype from CD4 +CD25 - T cells
2.Cloning, Expression, Purification of a Fusion Protein of SARS-CoV Nucleocapsid and Spike Protein Fragments and Its Immunological Characteristics
Rujing JIA ; Zhihong YUAN ; Jincun ZHAO ; Wei WANG ; Zhendong ZHAO ; Xiaoming GAO ; Xiaojun XU
Chinese Journal of Biochemistry and Molecular Biology 2005;21(6):748-755
The spike (S) and nucleocapsid (N) proteins, which are responsible for viral binding to cell surface receptors and the formation of ribonucleoprotein complexes during virion assembling, are major structure proteins of severe acute respiratory syndrome coronavirus (SARS-CoV). The expression of recombinant protein may give more accurate result for detecting SARS-CoV infection. A novel fusion protein,comprising of two fragments of N and S proteins from SARS-CoV, was prepared. Our computer-assisted analysis suggested that the immunodominant domains were located in the amino acid residues 1-227 of N protein and 450-650 of S protein, further the fusion of the two fragments did not change the immunochemical characteristics. The complementary DNA(cDNA) encoding N1-227 fused with S450-650 was obtained by sequence overlapping extension (SOE), and named NLS. It was cloned into pET-28a ( + ), an expression vector for His-tag fusion protein. This new constructed fusion protein was prokaryotic expressed in E. coli,and purified by metal chelate affinity chromatography with the purity over 95 %. The purified fusion protein was identified by anti-His monoclonal antibody and convalescence SARS patients serum. The NLS protein based ELISA showed that NLS maintained appropriate antigenicity and specificity to react with the sera of convalescent SARS patients. The functional NLS protein were successfully expressed and purified. And the fusion protein based ELISA can be used for detection of antibodies (Abs) against the S and N proteins of SARS-CoV. It may provided a novel diagnostic tool and have the potential application in developing of anti-SARS vaccine.
3.The clinical application of CT-guided microcoil positioning of small pulmonary nodules in video-assisted thoracic surgery
Huixia NI ; Wei ZHAO ; Jihong HU ; Tao WANG ; Wenqiu PAN ; Jincun SU ; An LI
Journal of Interventional Radiology 2017;26(6):555-559
Objective To assess the clinical value of preoperative CT-guided microcoil positioning of small solitary pulmonary nodule (SPN) in assisting video-assisted thoracic surgery (VATS) procedure to more quickly and more precisely remove small pulmonary lesions.Methods The clinical data of 90 patients with SPN,who were admitted to authors' hospital during the period from June 2014 to May 2016 to receive VATS,were retrospective analyzed.Preoperative CT-guided microcoil positioning of SPN was employed in 45 patients (group A),while other 45 patients (group B) did not receive preoperative positioning of SPN.The pulmonary lobar wedge resection time,the transfer rate of changing to open chest operation,postoperative hospitalization time,the success rate of microcoil positioning of SPN,complications,etc.of both groups were statistically analyzed.The safety of preoperative CT-guided microcoil positioning of SPN was evaluated,and its benefit-enhancing value for VATS was discussed.Results In group A,the success rate of VATS was 100% and the success rate of SPN positioning was 95.6%.Postoperative complications included pneumothorax (n=5),pulmonay surface hemorrhage (n=6),and dislodgement of microcoil (n=2).In group B,the success rate of VATS was 84.4% and the transfer rate of changing to open chest operation was 15.6%.In group A,the manipulation time of VATS was (17.7±2.8) min,the postoperative hospitalization time was (6.2±1.7) days,and the transfer rate of changing to open chest operation was 0%,which were strikingly lower than those in group B;the differences between the two groups were statistically significant (P<0.05).Conclusion Preoperative CT-guided microcoil positioning of small SPN can assist VATS procedure to remove small pulmonary lesions more quickly and more precisely,it can effectively reduce the transfer rate of changing to open chest operation,shorten the manipulation time of VATS as well as the postoperative hospitalization time.
4.Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.
Jiangping HE ; Shuijiang CAI ; Huijian FENG ; Baomei CAI ; Lihui LIN ; Yuanbang MAI ; Yinqiang FAN ; Airu ZHU ; Huang HUANG ; Junjie SHI ; Dingxin LI ; Yuanjie WEI ; Yueping LI ; Yingying ZHAO ; Yuejun PAN ; He LIU ; Xiaoneng MO ; Xi HE ; Shangtao CAO ; FengYu HU ; Jincun ZHAO ; Jie WANG ; Nanshan ZHONG ; Xinwen CHEN ; Xilong DENG ; Jiekai CHEN
Protein & Cell 2020;11(9):680-687
5.Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19.
Xiaoyan LIU ; Zhe LI ; Shuai LIU ; Jing SUN ; Zhanghua CHEN ; Min JIANG ; Qingling ZHANG ; Yinghua WEI ; Xin WANG ; Yi-You HUANG ; Yinyi SHI ; Yanhui XU ; Huifang XIAN ; Fan BAI ; Changxing OU ; Bei XIONG ; Andrew M LEW ; Jun CUI ; Rongli FANG ; Hui HUANG ; Jincun ZHAO ; Xuechuan HONG ; Yuxia ZHANG ; Fuling ZHOU ; Hai-Bin LUO
Acta Pharmaceutica Sinica B 2020;10(7):1205-1215
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause acute respiratory distress syndrome, hypercoagulability, hypertension, and multiorgan dysfunction. Effective antivirals with safe clinical profile are urgently needed to improve the overall prognosis. In an analysis of a randomly collected cohort of 124 patients with COVID-19, we found that hypercoagulability as indicated by elevated concentrations of D-dimers was associated with disease severity. By virtual screening of a U.S. FDA approved drug library, we identified an anticoagulation agent dipyridamole (DIP) , which suppressed SARS-CoV-2 replication . In a proof-of-concept trial involving 31 patients with COVID-19, DIP supplementation was associated with significantly decreased concentrations of D-dimers ( < 0.05), increased lymphocyte and platelet recovery in the circulation, and markedly improved clinical outcomes in comparison to the control patients. In particular, all 8 of the DIP-treated severely ill patients showed remarkable improvement: 7 patients (87.5%) achieved clinical cure and were discharged from the hospitals while the remaining 1 patient (12.5%) was in clinical remission.
6.A CRISPR activation screen identifies genes that enhance SARS-CoV-2 infection.
Fei FENG ; Yunkai ZHU ; Yanlong MA ; Yuyan WANG ; Yin YU ; Xinran SUN ; Yuanlin SONG ; Zhugui SHAO ; Xinxin HUANG ; Ying LIAO ; Jingyun MA ; Yuping HE ; Mingyuan WANG ; Longhai TANG ; Yaowei HUANG ; Jincun ZHAO ; Qiang DING ; Youhua XIE ; Qiliang CAI ; Hui XIAO ; Chun LI ; Zhenghong YUAN ; Rong ZHANG
Protein & Cell 2023;14(1):64-68